Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Dermatology

Free Subscription 10.08.2026 1 Am J Dermatopathol 2 Am J Ophthalmol 1 Am J Pathol 3 BMC Cancer 3 Br J Dermatol 1 Cancer 1 Cancer Res 3 Clin Dermatol 5 Clin Exp Dermatol 1 Hum Mutat 15 Int J Dermatol 1 Intern Med 6 J Cutan Pathol 12 J Dermatol 7 J Invest Dermatol 1 N Engl J Med 1 PLoS Comput Biol 4 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. SHABBIR A, Awh K, Gupta N, DeSimone MS, et al
   Primary Cutaneous Anaplastic Large Cell Lymphoma in a Patient With Li Fraumeni Syndrome.
   Am J Dermatopathol. 2026 Aug 3. doi: 10.1097/DAD.0000000000003398.
   PubMed         Abstract available
   
   

   
   Am J Ophthalmol

2. BELLANDA V, Schulgit MJ, Hassan KA, Kennedy LB, et al
   Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug Classes.
   Am J Ophthalmol. 2026 Jun 1:S0002-9394(26)00298.
   PubMed         Abstract available
   
   
3. KATE A, Wannapanich T, Huang AJW, Jhanji V, et al
   Conjunctival Biopsy in Ocular Mucous Membrane Pemphigoid.
   Am J Ophthalmol. 2026 Jun 1:S0002-9394(26)00290.
   PubMed         Abstract available
   
   

   
   Am J Pathol

4. KAGOYAMA K, Andoh T, Makino T, Yamamoto S, et al
   D-Dopachrome Tautomerase Facilitates UVB-Induced Skin Photoaging in Mice.
   Am J Pathol. 2026 Aug 7:S0002-9440(26)00228-2. doi: 10.1016/j.ajpath.2026.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. WEI Y, Qi Y, Ge H, Zeng C, et al
   Meta-analysis reveals pathological complete response benefits from neoadjuvant immuno-chemotherapy combination in patients with HER2-negative breast cancer.
   BMC Cancer. 2026 Jun 8. doi: 10.1186/s12885-026-16230.
   PubMed         Abstract available
   
   
6. WIGUNA IGWW, Sadeva IGKA, Mamangdean CT, Mahayana NPK, et al
   Atezolizumab versus pembrolizumab in the treatment of advanced triple-negative breast cancer: a Bayesian network meta-analysis of ITT and PD-L1 positive populations.
   BMC Cancer. 2026 May 29. doi: 10.1186/s12885-026-16207.
   PubMed         Abstract available
   
   
7. AWADA A, Tarhini A, Hammoud A, Kassem M, et al
   Hematologic toxicity of immune checkpoint inhibitors: real-world burden and risk profiles from a five-year cohort from the Middle East.
   BMC Cancer. 2026;26:915.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

8. MILLETTE D
   Durability of response to Icotrokinra in the ICONIC-ADVANCE 1 and ICONIC-ADVANCE 2 Trials: a potential new novel oral treatment for psoriasis.
   Br J Dermatol. 2026 Aug 7:ljag323. doi: 10.1093.
   PubMed        
   
   
9. SMAK GREGOOR AM, Wehrens R, van der Vall N, Benning T, et al
   Willingness to pay among individuals from the Dutch general population for artificial intelligence based apps for skin cancer detection: a survey-based mixed-methods study.
   Br J Dermatol. 2026 Aug 7:ljag327. doi: 10.1093.
   PubMed         Abstract available
   
   
10. SU Y, Wang T, Li L, Fang X, et al
    Proteomic Profiling Reveals a Cytokine-Chemokine Axis Involving CXCL10, CD40, and CCL17 in Dermatitis Herpetiformis Pathogenesis and Treatment Response.
    Br J Dermatol. 2026 Aug 3:ljag319. doi: 10.1093.
    PubMed        
    
    

    
    Cancer

11. HUANG L, Cook LS, Tang MC, Doody DR, et al
    Relationship between bisphosphonate use and risks of recurrence and mortality among hormone receptor-positive and triple-negative breast cancer patients.
    Cancer. 2026;132:e70562.
    PubMed         Abstract available
    
    

    
    Cancer Res

12. NAPOLITANO F, Hanker AB
    Shaping CDK4/6 Inhibitor Resistance: BRCA2 Germline Alterations Bias toward RB1 Inactivation.
    Cancer Res. 2026;86:3631-3633.
    PubMed         Abstract available
    
    

    
    Clin Dermatol

13. MACKENZIE J, Kels GG, Staunton MK, Grant-Kels JM, et al
    Cutaneous Manifestations of Carcinoid Tumor and Syndrome.
    Clin Dermatol. 2026 Aug 4:S0738-081X(26)00196.
    PubMed         Abstract available
    
    
14. ZIENELDIEN T, Ma S, Succaria F, Grant-Kels JM, et al
    When Skin Disease Affects Intimacy: The Ethical Duty for Dermatologists to Screen for Sexual Dysfunction.
    Clin Dermatol. 2026 Aug 8:S0738-081X(26)00216.
    PubMed         Abstract available
    
    
15. MEHTA S
    "Mechanism of action: GLP-1 receptors in skin biology".
    Clin Dermatol. 2026 Aug 8:S0738-081X(26)00214.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

16. UTAMI NN, Muchtar SV, Krismawati H, Patinggi AL, et al
    Fear of clofazimine-induced skin discoloration as a barrier to leprosy treatment: urgent need for alternative therapeutic options.
    Clin Exp Dermatol. 2026 Aug 4:llag349. doi: 10.1093.
    PubMed        
    
    
17. LEE ML, Evans A, Foerster J
    A Persistent Erythematous Plaque on the Posterior Thigh of an Elderly Man Masked by Senile Dermatitis.
    Clin Exp Dermatol. 2026 Aug 1:llag342. doi: 10.1093.
    PubMed        
    
    
18. KHAN S, Patel NP
    Patient-requested surveillance for suspected acral melanoma: balancing autonomy and clinical risk.
    Clin Exp Dermatol. 2026 Aug 1:llag341. doi: 10.1093.
    PubMed        
    
    
19. HO W, Chen YM, Lin MW, Liao YQ, et al
    Pulsed Azithromycin for the Treatment of Dacomitinib Induced Skin Toxicity in Patient with Tetracycline Intolerance - A Case Report.
    Clin Exp Dermatol. 2026 Aug 1:llag346. doi: 10.1093.
    PubMed         Abstract available
    
    
20. TOUS-ROMERO F, Palencia-Perez SI, Ortiz-De Frutos J
    Treatment-Free Disease Control After Discontinuation of Advanced Therapies in Atopic Dermatitis: a real-world experience.
    Clin Exp Dermatol. 2026 Aug 1:llag335. doi: 10.1093.
    PubMed        
    
    

    
    Hum Mutat

21. CHOWDHURY MH, Shaolin FB, Khusbu NT, Puja UG, et al
    ESR1 and PIK3CA Polymorphisms as Potential Genetic Susceptibility Markers for Breast Cancer Risk in Bangladeshi Women: A Case-Control Study.
    Hum Mutat. 2026;2026:3651302.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

22. JING FZ, Meves A
    The Biological Basis of the Merlin CP-GEP Assay: Integrin Signaling and Early Metastatic Competence in Cutaneous Melanoma.
    Int J Dermatol. 2026 Aug 3. doi: 10.1111/ijd.70610.
    PubMed         Abstract available
    
    
23. LUOTTI L, Brunello C, di Meo N, Zalaudek I, et al
    Prolonged Untreated Stability in Zosteriform Cutaneous Melanoma Metastases.
    Int J Dermatol. 2026 Aug 4. doi: 10.1111/ijd.70618.
    PubMed        
    
    
24. ALVARENGA JM, Yeung J, Prajapati V, Ribero S, et al
    Prevalence of Regulatory Safety Risk Factors Among Adolescents and Adults With Atopic Dermatitis Receiving Advanced Systemic Therapies: An International Real-World Study.
    Int J Dermatol. 2026 Aug 4. doi: 10.1111/ijd.70617.
    PubMed        
    
    
25. BOOSTANI M, Goorman EJ, Bax MJ, Brady KL, et al
    Mohs Margins in Stage-1-Positive Basal Cell Carcinoma Are Often Histologically Shallow Irrespective of Biopsy Subtype: A Retrospective Analysis Using Histologic Depth as a Surrogate for In Vivo Imaging Detectability.
    Int J Dermatol. 2026 Aug 5. doi: 10.1111/ijd.70608.
    PubMed         Abstract available
    
    
26. UGURLU S, Yildiz P, Dayi G
    Orf-Like Ulcerated Digital Nodule as a Cutaneous Manifestation of VEXAS Syndrome.
    Int J Dermatol. 2026 Aug 5. doi: 10.1111/ijd.70619.
    PubMed        
    
    
27. DE A, Chakraborty D
    Comorbidity Burden and Biologic Access in Uninsured Patients With Psoriasis.
    Int J Dermatol. 2026 Aug 7. doi: 10.1111/ijd.70626.
    PubMed        
    
    
28. MELGOSA RAMOS FJ, Sanz Motilva V, Sabater Abad J, Vila Cobreros L, et al
    Special, Sensitive, and Difficult-to-Treat Areas: Clarifying the Terminology in Atopic Dermatitis.
    Int J Dermatol. 2026 Aug 8. doi: 10.1111/ijd.70628.
    PubMed         Abstract available
    
    
29. TURK M, Yucel MB, Yilmaz I, Ertas R, et al
    Dysmenorrhea in Chronic Spontaneous Urticaria: A Subset of Patients Report Worsening and Partial Antihistamine Benefit: UCARE HURDLE-I Study.
    Int J Dermatol. 2026;65:1838-1845.
    PubMed         Abstract available
    
    
30. TOGNETTI L, Pasquali P, Moscarella E, Miracapillo C, et al
    European Dermatologists' Perception and Awareness of Teledermatology Use: Results From an International Survey Promoted by the EADV Teledermatology Task Force.
    Int J Dermatol. 2026;65:1873-1881.
    PubMed         Abstract available
    
    
31. GUDER S, Kucuk OS, Dizman D, Temiz SNY, et al
    The Impact of Steroid Use on Scabies Treatment: An Evaluation of Clinical Severity, Parasite Burden, and the Validity of a Novel Scoring System.
    Int J Dermatol. 2026;65:1856-1863.
    PubMed         Abstract available
    
    
32. GUPTA AK, Teasell EM, Liddy A, Economopoulos V, et al
    Scalp Microbiome Alterations in Androgenetic Alopecia: Patterns and Emerging Mechanistic Insights.
    Int J Dermatol. 2026;65:1828-1837.
    PubMed         Abstract available
    
    
33. DI GIROLAMO A, Cristallo M
    Steroid-Modified Scabies: Quantifying a Clinically Recognized but Understudied Problem.
    Int J Dermatol. 2026;65:1802-1803.
    PubMed         Abstract available
    
    
34. LONG V, Choi EC
    Navigating Teledermatology in the Post-COVID Era.
    Int J Dermatol. 2026;65:1804-1805.
    PubMed         Abstract available
    
    
35. WU J, Wang H, Sang J
    A Crateriform Facial Nodule in a Man With Pulmonary Tuberculosis.
    Int J Dermatol. 2026;65:1808-1810.
    PubMed         Abstract available
    
    
36. KEMENY L
    Editor's Highlights-September 2026.
    Int J Dermatol. 2026;65:1799-1801.
    PubMed         Abstract available
    
    

    
    Intern Med

37. SUZUKI T, Ishikawa M, Yamaguchi T, Miyata M, et al
    Scleroderma Renal Crisis and Posterior Reversible Encephalopathy Syndrome Triggered by Non-steroidal Anti-inflammatory Drugs.
    Intern Med. 2026;65:2124-2129.
    PubMed         Abstract available
    
    

    
    J Cutan Pathol

38. FREAR CC, Frear L, Lambie D, Godbolt A, et al
    The Accuracy of Frozen Section Histopathology in the Rapid Diagnosis of Severe Cutaneous Adverse Reactions: A Systematic Review and Meta-Analysis.
    J Cutan Pathol. 2026 Aug 2. doi: 10.1111/cup.70185.
    PubMed         Abstract available
    
    
39. CHRISTIE-NGUYEN B, Kim YH, Fiorentino DF, Tartar D, et al
    Primary Cutaneous Gamma-Delta T-Cell Lymphoma Complicating Long-Standing Immunosuppressed Dermatomyositis.
    J Cutan Pathol. 2026 Aug 4. doi: 10.1111/cup.70190.
    PubMed         Abstract available
    
    
40. HOMSI HA, Piliang M, Lucas J, Ko JS, et al
    Rare Secondary Neoplasms Arising in Epidermal Nevus: A Case Series and Literature Review.
    J Cutan Pathol. 2026;53:772-782.
    PubMed         Abstract available
    
    
41. MONTAZER F, Malekan M, Abedi H
    Immunohistochemical Evaluation of GATA3 Expression in Patch-Stage Mycosis Fungoides (MF) Compared With Benign Inflammatory Dermatoses (BID).
    J Cutan Pathol. 2026;53:824-831.
    PubMed         Abstract available
    
    
42. CALISKAN HN, Findik S, Kilinc F, Oltulu P, et al
    CADM1 and TIAM1 Expressions in Mycosis Fungoides: Diagnostic Significance and Association With Histopathological Parameters.
    J Cutan Pathol. 2026;53:832-843.
    PubMed         Abstract available
    
    
43. KUMAR D, Panse G, Ko CJ
    VEXAS Syndrome: Clues to Avoid Vexation.
    J Cutan Pathol. 2026;53:862-868.
    PubMed         Abstract available
    
    

    
    J Dermatol

44. DING L, Chen J, Dong X
    Hepatic Steatosis in Biologic-Treated Patients With Psoriasis and Low Current Disease Activity: Prevalence and Metabolic Determinants.
    J Dermatol. 2026 Aug 2. doi: 10.1111/1346-8138.70441.
    PubMed         Abstract available
    
    
45. YAMAMURA Y, Fujii K, Kagawa N, Nakajima M, et al
    A Recurrent-Depth Multimodal Model for Skin Lesion Classification: A Feasibility Study Using Derm7pt.
    J Dermatol. 2026 Aug 2. doi: 10.1111/1346-8138.70442.
    PubMed        
    
    
46. MUTO Y, Fujimura T, Kobayashi A, Segawa K, et al
    Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.
    J Dermatol. 2026 Aug 2. doi: 10.1111/1346-8138.70433.
    PubMed         Abstract available
    
    
47. OKUBO Y, Morita A, Tada Y, Imafuku S, et al
    Safety and Efficacy of Deucravacitinib in Japanese Patients With Moderate to Severe Plaque Psoriasis: 5-Year Analysis of the Phase 3 POETYK PSO-1, PSO-4, and Long-Term Extension Trials.
    J Dermatol. 2026 Aug 5. doi: 10.1111/1346-8138.70392.
    PubMed         Abstract available
    
    
48. IINO K, Takamura S, Fukuda T
    Real-World Effectiveness, Treatment Course, and Safety of Tapinarof Cream 1% for Atopic Dermatitis and Plaque Psoriasis in Japan.
    J Dermatol. 2026 Aug 6. doi: 10.1111/1346-8138.70448.
    PubMed         Abstract available
    
    
49. PENG X, Wang Y, Xiao Y, Wang H, et al
    Arthralgia and Ultrasound Characteristics of Subclinical Psoriatic Arthritis: A Cross-Sectional Study Based on the SPAWCH Cohort.
    J Dermatol. 2026;53:1133-1141.
    PubMed         Abstract available
    
    
50. SATO A, Matsui Y, Kitayama S, Shimizu T, et al
    Persistence and Contemporary Clinical Applications of Mohs Paste: A Scoping Review.
    J Dermatol. 2026;53:1083-1089.
    PubMed         Abstract available
    
    
51. WONGJIRATTIKARN R, Chanprapaph K, Rerknimitr P, Chularojanamontri L, et al
    Incidence Trends and Severe in-Hospital Outcomes of Pemphigus Vulgaris: A Nationwide Cohort Study.
    J Dermatol. 2026;53:1142-1152.
    PubMed         Abstract available
    
    
52. TANEMURA A, Oiso N, Okamura K, Hiroyasu S, et al
    Second Guidelines for the Diagnosis and Treatment of Vitiligo in Japan (2025).
    J Dermatol. 2026;53:e620-e638.
    PubMed         Abstract available
    
    
53. UCHIDA M, Hamada T, Kawashima H, Yamada T, et al
    Apremilast for Acrodermatitis Continua of Hallopeau: Report of Two Cases and Review of the Literature.
    J Dermatol. 2026;53:1198-1202.
    PubMed         Abstract available
    
    
54. AOYAMA M, Hagihara E, Furuya Y, Koshikawa S, et al
    Occupational Primary Red Meat Allergy With Sensitization to Serum Albumins, Sus s 1, and Bos d 6.
    J Dermatol. 2026 Jul 6. doi: 10.1111/1346-8138.70379.
    PubMed         Abstract available
    
    
55. KANNO K, Kobayashi Y, Fujita Y
    Nodular Scleroderma in a Patient With Anti-RNA Polymerase III-Antibody Positive Systemic Sclerosis: A Case Report and Literature Review.
    J Dermatol. 2026;53:1213-1216.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

56. KEREN A, Goldstein N, Bertolini M, Kassem R, et al
    Toward cell-based therapy of alopecia areata: Autologous human Vdelta2(+) Foxp3(+) gammadeltaTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo.
    J Invest Dermatol. 2026;146:2128-2146.
    PubMed         Abstract available
    
    
57. GANESAN AK, Ezzedine K, Hanna S, Rashighi M, et al
    Three-dimensional imaging for facial vitiligo: Results from a phase 2 randomized controlled trial investigating upadacitinib in patients with vitiligo.
    J Invest Dermatol. 2026;146:2159-2167.
    PubMed         Abstract available
    
    
58. ALAM R, Menon AA, Ch'en PY, Jabbour AJ, et al
    Clinical benefit of adding radiation for immune checkpoint inhibitor-refractory Merkel cell carcinoma: A 27-patient analysis.
    J Invest Dermatol. 2026;146:2168-2175.
    PubMed         Abstract available
    
    
59. NOLDEN K, Shi Y, Batista VS, Bunick CG, et al
    Molecular differentiation of OX40- and OX40L-targeted biologics using AlphaFold3 and molecular dynamics simulations.
    J Invest Dermatol. 2026;146:2267-2279.
    PubMed         Abstract available
    
    
60. KOHLING V, Peters F, Gotting I, Fries E, et al
    Regulation of keratinocyte proliferation and epidermal inflammation by meprin alpha-mediated cleavage of dermokine.
    J Invest Dermatol. 2026;146:2189-2203.
    PubMed         Abstract available
    
    
61. LEE J, Ham S, Lee J, Krueger JG, et al
    Spatial transcriptomics maps early B-cell and T-cell activation in hidradenitis suppurativa.
    J Invest Dermatol. 2026;146:2147-2158.
    PubMed         Abstract available
    
    
62. LIM HW, Schalka S, Trautinger F, Baptista MS, et al
    International modified Delphi consensus statement on visible light photoprotection: Effects, measurement, and recommendations.
    J Invest Dermatol. 2026;146:2094-2104.
    PubMed         Abstract available
    
    

    
    N Engl J Med

63. TAPLIN ME, Gleave M, Shore ND, Lopez-Gitlitz A, et al
    Perioperative Apalutamide in High-Risk Localized Prostate Cancer.
    N Engl J Med. 2026 May 31. doi: 10.1056/NEJMoa2603878.
    PubMed         Abstract available
    
    

    
    PLoS Comput Biol

64. STANCIU A, Gombos A, Agostinetto E, Vincent D, et al
    ALFAssay: A feed?forward neural network for quantitative fragmentomics?based ctDNA profiling in breast cancer.
    PLoS Comput Biol. 2026;22:e1014505.
    PubMed         Abstract available
    
    

    
    PLoS One

65. SANTOS ADL, Pascoal-Xavier MA, Peruhype-Magalhaes V, Eller MTC, et al
    Anti-Leishmania activated C-kinase monoclonal antibody immunohistochemical technique for cutaneous leishmaniasis diagnosis.
    PLoS One. 2026;21:e0339746.
    PubMed         Abstract available
    
    
66. ARTHUR P, Boamah Mensah AB, Boamah Mensah K, Konney TO, et al
    Gatekeepers or barriers? Exploring traditional medicine practitioners' understanding of breast cancer in Ghana.
    PLoS One. 2026;21:e0355289.
    PubMed         Abstract available
    
    
67. DU M, Zhu W, Wang S, Wang R, et al
    Leveraging expression quantitative trait loci information in single-cell resolution to identify cell-specific genes for Basal cell carcinoma.
    PLoS One. 2026;21:e0354887.
    PubMed         Abstract available
    
    
68. MOTAGANAHALLI S, Vogrin S, Richards T, Peel T, et al
    Pilot randomised controlled trial of probe to bone diabetic foot ulcer therapy (PROBE-DFU trial) - Study protocol.
    PLoS One. 2026;21:e0354611.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

69. LIU X, Liu Y, Li J, Wang Z, et al
    High-throughput deformability-based microfluidic sorting reveals metastatic cancer subpopulations.
    Proc Natl Acad Sci U S A. 2026;123:e2604094123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum